Atlas Trials

Carboplatin and Etoposide With or Without Oblimersen Sodium in Treating Patients With Extensive Stage Small Cell Lung Cancer

Clinical trial NCT00042978 · COMPLETED

Trial details

NCT number
NCT00042978
Sponsor
National Cancer Institute (NCI)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Extensive Stage Small Cell Lung CancerRecurrent Small Cell Lung Cancer
Start date
2003-04-01
Primary completion
2005-05-01
Enrollment
55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.